Arthritis Research & Therapy

official impact factor 4.36

This article is part of the supplement: Interleukin-6, a pleiotropic cytokine

Highly Access

Interleukin-6: a new therapeutic target

Josef S Smolen* and Ravinder N Maini

Arthritis Research & Therapy 2006, 8(Suppl 2):S5 doi:10.1186/ar1969

Accesses  

  • Last 30 days: 108 accesses
  • Last year: 1148 accesses
  • All time: 10832 accesses

Cited by

BioMed Central: 4 citations

Research article   Open Access

In vitro model for the analysis of synovial fibroblast-mediated degradation of intact cartilage

David Pretzel, Dirk Pohlers, Sönke Weinert, Raimund W Kinne Arthritis Research & Therapy 2009, 11:R25 (18 February 2009)

Research article   Open Access

Therapeutic effects of antibodies to tumor necrosis factor-α, interleukin-6 and cytotoxic T-lymphocyte antigen 4 immunoglobulin in mice with glucose-6-phosphate isomerase induced arthritis

Isao Matsumoto, Hua Zhang, Takanori Yasukochi, Keiichi Iwanami, Yoko Tanaka, Asuka Inoue, Daisuke Goto, Satoshi Ito, Akito Tsutsumi, Takayuki Sumida Arthritis Research & Therapy 2008, 10:R66 (5 June 2008)

Review   Free Highly Accessed

Cells of the synovium in rheumatoid arthritis. Macrophages

Raimund W Kinne, Bruno Stuhlmüller, Gerd-R Burmester Arthritis Research & Therapy 2007, 9:224 (21 December 2007)

This article is part of a collection on Cells of the synovium in...

Correction   Free

Correction: Interleukin-6: a new therapeutic target

Josef S Smolen, Ravinder N Maini Arthritis Research & Therapy 2006, 8:407 (17 October 2006)